newsfilter
← Latest News
GlobeNewswire·

Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine

BROOMFIELD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary